Cutaneous Oncology News

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.

Healio has compiled June’s most-read news in dermatology.

Iovance Biotherapeutics has submitted a marketing authorization application to the European Medicines Agency for lifileucel to treat advanced melanoma, the company announced in a press release.

Rural populations, especially those with skin of color, experience higher prevalence and an increased risk for skin cancer, according to a study.

IceCure Medical has received marketing authorization from the FDA for its next-generation single probe cryoablation system, the company announced in a press release.

Prior radiotherapy was associated with progression-free survival in patients with metastatic cutaneous squamous cell carcinoma treated with cemiplimab, according to a study.

Individuals with skin of color experience barriers to sunscreen usage, warranting dermatologists and other health care providers to address these challenges, according to a study.

Factors such as age, tumor size and immunosuppression are linked with survival outcomes in localized adnexal carcinomas, according to a study.

DermTech has filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware, the company announced in a press release.

Suntegrity Skincare has issued a voluntary recall of nine Impeccable Skin Sunscreen Foundation lots, according to a press release from the FDA.